Stay updated on KN035 Anti-PD-L1 Clinical Trial

Sign up to get notified when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN035 Anti-PD-L1 Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor deployment update to the page or platform with no visible content changes.
    Difference
    0.1%
    Check dated 2026-05-14T23:12:43.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    A new publication citation was added under Publications. It references a 2024 Oncologist article about envafolimab (PD-L1 antibody) in advanced solid tumors.
    Difference
    0.1%
    Check dated 2026-05-07T18:30:02.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.2 to v3.5.3, indicating an update to the page's version in the site's revision history. This reflects an administrative update to the page metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-04-30T15:34:00.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:05.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    - Revision changed from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:14:24.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:44:51.000Z thumbnail image

Stay in the know with updates to KN035 Anti-PD-L1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.